These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23925980)

  • 21. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis.
    Toms TE; Panoulas VF; Smith JP; Douglas KM; Metsios GS; Stavropoulos-Kalinoglou A; Kitas GD
    Ann Rheum Dis; 2011 Jun; 70(6):1025-32. PubMed ID: 21398331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Charles-Schoeman C; Wang X; Lee YY; Shahbazian A; Navarro-Millán I; Yang S; Chen L; Cofield SS; Moreland LW; O'Dell J; Bathon JM; Paulus H; Bridges SL; Curtis JR
    Arthritis Rheumatol; 2016 Mar; 68(3):577-86. PubMed ID: 26606398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting.
    An J; Cheetham TC; Reynolds K; Alemao E; Kawabata H; Liao KP; Solomon DH
    Arthritis Care Res (Hoboken); 2016 May; 68(5):629-37. PubMed ID: 26414069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?
    Fernández-Ortiz AM; Ortiz AM; Pérez S; Toledano E; Abásolo L; González-Gay MA; Castañeda S; González-Álvaro I
    Arthritis Res Ther; 2020 Sep; 22(1):213. PubMed ID: 32917272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.
    Zou YW; Wu T; Li QH; Ma JD; Pan J; Lu Y; Lin JZ; Jia PW; Zheng HW; Gao JW; Dai W; Mo YQ; Dai J; Dai L
    Int J Cardiol; 2024 Jun; 405():131947. PubMed ID: 38458390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib.
    Charles-Schoeman C; Fleischmann R; Davignon J; Schwartz H; Turner SM; Beysen C; Milad M; Hellerstein MK; Luo Z; Kaplan IV; Riese R; Zuckerman A; McInnes IB
    Arthritis Rheumatol; 2015 Mar; 67(3):616-25. PubMed ID: 25470338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
    Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
    J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.
    Park YB; Choi HK; Kim MY; Lee WK; Song J; Kim DK; Lee SK
    Am J Med; 2002 Aug; 113(3):188-93. PubMed ID: 12208376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.
    Rizzo M; Spinas GA; Cesur M; Ozbalkan Z; Rini GB; Berneis K
    Atherosclerosis; 2009 Dec; 207(2):502-6. PubMed ID: 19643412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.
    Chung CP; Oeser A; Raggi P; Sokka T; Pincus T; Solus JF; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2010 Aug; 37(8):1633-8. PubMed ID: 20516025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy].
    Hansel B; Bruckert E
    Ann Endocrinol (Paris); 2010 Sep; 71(4):257-63. PubMed ID: 20416859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Qiu C; Zhao X; She L; Shi Z; Deng Z; Tan L; Tu X; Jiang S; Tang B
    Lipids Health Dis; 2019 Feb; 18(1):54. PubMed ID: 30777075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients.
    Behl T; Kaur I; Sehgal A; Zengin G; Brisc C; Brisc MC; Munteanu MA; Nistor-Cseppento DC; Bungau S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness].
    Carotti M; Salaffi F; Mangiacotti M; Cerioni A; Giuseppetti GM; Grassi W
    Reumatismo; 2007; 59(1):38-49. PubMed ID: 17435841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
    Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.
    Dursunoğlu D; Evrengül H; Polat B; Tanriverdi H; Cobankara V; Kaftan A; Kiliç M
    Rheumatol Int; 2005 May; 25(4):241-5. PubMed ID: 15290086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipoproteinemia in the course of active rheumatoid arthritis.
    Lazarevic MB; Vitic J; Mladenovic V; Myones BL; Skosey JL; Swedler WI
    Semin Arthritis Rheum; 1992 Dec; 22(3):172-8. PubMed ID: 1295090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.
    Myasoedova E; Crowson CS; Kremers HM; Roger VL; Fitz-Gibbon PD; Therneau TM; Gabriel SE
    Ann Rheum Dis; 2011 Mar; 70(3):482-7. PubMed ID: 21216812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.